Evidence map›Paper›PMID 32853602›Full record

ArticleThe Journal of infection2020

Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.

Eve Garrigues, Paul Janvier, Yousra Kherabi, Audrey Le Bot, Antoine Hamon, Hélène Gouze, Lucile Doucet, Sabryne Berkani, Emma Oliosi, Elise Mallart and 7 more

4 registry-linked trialsAbstract readLetter
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 581 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
581citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04647656 narecruitingnot on this mapstarted 2023, after this paper: background citation

Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome: a Prospective, Randomized, Double Blind Study.

TypeinterventionalSponsorAssaf-Harofeh Medical CenterRan2023 to 2027Enrolled91ConditionsCovid19, Neurocognitive DysfunctionArmsHyperbaric oxygen, Sham
NCT04988126 unknown statusnot on this mapstarted 2021, after this paper: background citation

Assessment of Pain, Fatigue and Quality of Life in COVID-19 Patients

TypeobservationalSponsorAfyonkarahisar Health Sciences UniversityRan2021 to 2022Enrolled150ConditionsCOVID-19 Pneumonia, Pain, Fatigue, Quality of LifeArmsInterventions
NCT05587868 unknown statusnot on this mapstarted 2022, after this paper: background citation

Karakteristik Dan Pengaruh Vaksinasi COVID-19 Terhadap Klinis Dan Kualitas Hidup Pasien Long COVID di RSUPN Dr. Cipto Mangunkusumo

TypeobservationalSponsorIndonesia UniversityRan2022 to 2023Enrolled250ConditionsCOVID-19, SARS CoV-2 InfectionArmsCOVID-19 Vaccine
NCT05669261 phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

A PILOT STUDY ON RESEARCH TREATMENT OF LONG COVID POST-ACUTE SEQUELAE OF SARS CoV-2 INFECTION ("PASC") USING ATCell™

TypeinterventionalSponsorAmerican CryoStem CorporationRan2023 to 2024Enrolled20ConditionsLong COVIDArmsAdipose Tissue Harvest, ATCell
3 · Its place in the literature

Who cites it

581 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

521 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Eve GarriguesDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Paul JanvierDepartment of Radiology, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Yousra KherabiDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Audrey Le BotDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Antoine HamonDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Hélène GouzeDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Lucile DoucetDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Sabryne BerkaniDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Emma OliosiDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Elise MallartDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Félix CorreDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Virginie ZarroukDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Jean-Denis MoyerDepartment of Anaesthesiology and Intensive Care, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Adrien GalyDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Vasco HonselDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Bruno FantinDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France.
Yann NguyenDepartement of Internal Medicine, AP-HP.Nord, Beaujon Hospital, University of Paris, Clichy, France; Centre for Epidemiology and Population Health, INSERM U1018, Villejuif, France. Electronic address: yann.nguyen2@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess post-discharge persistent symptoms and health-related quality of life (HRQoL) of patients hospitalized in a COVID-19 ward unit more than 100 days after their admission.

methodsAll eligible patients were contacted by phone by trained physicians and were asked to answer to a dedicated questionnaire. Patients managed in hospital ward without needing intensive care were compared with those who were transferred in intensive care units (ICU).

resultsWe included 120 patients after a mean (±SD) of 110.9 (±11.1) days following admission. The most frequently reported persistent symptoms were fatigue (55%), dyspnoea (42%), loss of memory (34%), concentration and sleep disorders (28% and 30.8%, respectively). Comparisons between ward- and ICU patients led to no statistically significant differences regarding those symptoms. In both group, EQ-5D (mobility, self-care, pain, anxiety or depression, usual activity) was altered with a slight difference in pain in the ICU group.

conclusionMost patients requiring hospitalization for COVID-19 still have persistent symptoms. While there were few differences between HRQoL between ward and ICU patients, our findings must be confirmed in larger cohorts, including more severe patients.

Indexed as

HospitalizationPatient DischargeQuality of LifeAgedAged, 80 and overAnxietyCOVID-19FatigueFemaleHumansIntensive Care UnitsMaleMiddle AgedPainSARS-CoV-2Surveys and QuestionnairesCovid-19Health-related quality of lifePersistent symptoms

Identifiers

PMID32853602
PMCPMC7445491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.